Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance
International Journal of Research in Pharmacy and Allied Science · 2026 · 05 (10) · 93-108
DOI: 10.71431/ijrpas.2026.51005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Research in Pharmacy and Allied Science, 2026. Verfasst von Sunil Sajjan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
The study aimed to formulate and evaluate Oro-dispersible film of solubility enhanced Aripiprazole for the management of psychosis.
Methods
Aripiprazole–methyl-β-cyclodextrin inclusion complexes (1:0.5 to 1:1.5) were freeze-dried and characterized by KBr-pellet FTIR spectroscopy. Films (F1–F9) were prepared via solvent casting using Pullulan (300–500 mg) and PEG 400 (125–325 mg) based on a 32 factorial design. Evaluated parameters included film thickness, weight variation, surface pH, folding endurance, disintegration time, drug content uniformity, and in-vitro release in pH 6.8 phosphate buffer.
Results
FTIR confirmed drug–excipient compatibility with no degradation of major drug peaks (N–H at 3261 cm⁻¹, C=O at 1673 cm⁻¹). Across formulations F1 to F9, thickness was 0.07–0.12 mm, weight 0.047–0.101 mg, surface pH 6.2–6.9, folding endurance 40–58, disintegration time 34–42 s, drug content 87.11–96.91%, and in-vitro release 89.58–100.26%. Formulation F5 (400 mg pullulan, 225 mg PEG 400) was optimized, displaying 0.10 mm thickness, 0.071 mg weight, 6.8 surface pH, 50 folding endurance, 38 s disintegration time, 96.91% drug content, and 93.53% drug release. Low percentage errors (< 5%) validated the response surface model.
Conclusion
Optimized film F5 provides rapid oral disintegration, high flexibility, near-neutral pH compatibility, and fast drug release, serving as an effective, patient-compliant platform for psychosis treatment.
Zitieren
APA
Sajjan, S., Kotwal, G., Desai, A. R., & Vijapur, L. S. (2026). Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance. International Journal of Research in Pharmacy and Allied Science, 05(10), 93-108. https://doi.org/10.71431/ijrpas.2026.51005
Vancouver
Sajjan S, Kotwal G, Desai AR, Vijapur LS. Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance. International Journal of Research in Pharmacy and Allied Science. 2026;05(10):93-108. doi:10.71431/ijrpas.2026.51005
BibTeX
@article{Sajjan2026,
author = {Sajjan, Sunil and Kotwal, Ganisab and Desai, Anita R and Vijapur, Laxman S},
title = {Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance},
journal = {International Journal of Research in Pharmacy and Allied Science},
year = {2026},
volume = {05},
number = {10},
pages = {93--108},
doi = {10.71431/ijrpas.2026.51005}
}
EUVIMED